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Abstract
Ganoderma lucidum, a well-known medicinal mushroom, is highly valued and com-
monly used in Oriental medicine. Although recent experimental data has revealed 
the proapoptotic potency of G. lucidum extracts, the underlying mechanisms of 
this apoptotic activity have not yet been studied in detail. In the present study, the 
effects of ethanol extracts of G. lucidum (EGL) on the growth of an AGS human gas-
tric carcinoma cell line were investigated. We found that EGL treatment resulted in 
a dose- and time-dependent significant decrease in the viability of AGS cells. This 
decreased viability was caused by apoptotic cell death, with observed chromatin 
condensation and an accumulation of apoptotic fraction. EGL treatment induced 
the expression of death receptor-related proteins such as death receptor 5 and 
tumor necrosis factor-related apoptosis-inducing ligand, which further triggered 
the activation of caspase-8 and the cleavage of Bid. In addition, the increase in 
apoptosis that was induced by EGL was correlated with activation of caspase-9 
and -3, downregulation of IAP family proteins such as XIAP and survivin, and con-
comitant degradation of poly (ADP-ribose) polymerase. Moreover the activity of 
Akt was downregulated in EGL-treated cells, and the phosphatidylinositol-3 kinase/
Akt inhibitor LY294002 sensitized the cells to EGL-induced apoptosis. The results 
indicated that EGL induces the apoptosis of AGS cells through a signaling cascade 
of death receptor-mediated extrinsic, as well as mitochondria-mediated intrinsic, 
caspase pathways which are associated with inactivation of the Akt signal pathway.
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1.  Introduction
Apoptosis is the active process of programmed 
cell death that occurs during many important 
physiological conditions and has become an area 
of extensive study in cancer research for an ideal 
way of elimin ating precancerous and/or cancerous 
cells [1,2]. Apoptosis is characterized by a series 
of distinct morphological and biochemical altera-
tions to cells such as plasma membrane blebbing, 
cell shrinkage, cell surface expression of phos-
phatidylserine, depolarization of the mitochondria, 
chromatin condensation, and DNA fragmentation. 
In general, apoptosis can be initiated in two ways: 
by the death receptor (DR; extrinsic) pathway or 
by the mitochondria-dependent (intrinsic) path-
way, leading to activation of caspases and conse-
quent apoptosis in mammalian cells [3−5]. In the 
former case, plasma membrane DRs are involved 
and the apoptosis signal is provided by the inter-
action between the ligand and death receptor. 
Changes in mitochondrial integrity caused by a 
broad range of physical and chemical stimuli, 
however, can trigger the intrinsic pathway of ap-
optosis [2,6,7]. Recent evidence has also shown 
that phosphatidylinositol-3 kinase (PI3K)/Akt is 
modulated in response to a variety of stimuli, in 
particular, the activation of Akt signaling promotes 
survival [8,9].
As a traditional medicine, Ganoderma lucidum 
( , lingzhi in Chinese or reishi in Japanese), a 
polypore mushroom that grows on the lower trunks 
of deciduous trees, has been widely used as a tonic 
in promoting longevity and health in Korea and 
other Asian countries [10−13]. The pharmacologi-
cal activities of G. lucidum, especially its intrinsic 
immunomodulating and anti-tumor properties, 
have been extensively documented [13−16]. Recently, 
several studies have demonstrated that G. lucidum 
extracts (EGL) interfere with cell cycle progres-
sion, induce apoptosis, and suppress angiogenesis 
in human cancer cells to act as anticancer agents 
[17−25]. However, the precise mechanisms of ap-
optosis induction of EGL are largely unknown in 
human cancer cells.
The present study attempts to elucidate 
the apoptotic potential of the ethanol extracts of 
EGL in an AGS human gastric carcinoma cell line. 
The underlying intracellular signal transduction 
pathways involved in regulating apoptosis were 
also investigated. The results of this study de-
monstrated that EGL induces the apoptosis of 
AGS cells through a signaling cascade of death 
receptor-mediated extrinsic and mitochondria-
mediated intrinsic caspase pathways, which are 
associated with inactivation of the Akt signal 
pathway.
2.  Materials and Methods
2.1.  Cell culture, preparation of ethanol 
extracts of EGL and cell viability assay
Human gastric carcinoma AGS cell line was purchased 
from the American Type Culture Collection (Rockville, 
MD, USA). AGS cells were cultured in RPMI 1640 
medium (Gibco BRL, Gaithersburg, MD, USA) sup-
plemented with 10% fetal bovine serum and 1% 
penicillin−streptomycin in a 37ºC incubator with 
5% CO2. The preparation of ethanol extracts of EGL 
occurred at Dongeui University Oriental Hospital, 
Busan, Korea. The freeze-dried and milled fruiting 
body of G. lucidum (200 g) was extracted with 25% 
ethanol (4 L) at room temperature for 10 hours using 
a blender. The extracts were filtered through a 
Whatman #2 filter (Whatman, Maidstone, UK) con-
centrated to 500 mL under vacuum, and then kept 
at −20ºC. The EGL solution obtained was directly di-
luted in the medium before assay. Measurement of 
cell viability was determined using the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium 
bromide (MTT; Sigma-Aldrich, St. Louis, MO, USA) 
assay, which is based on the conversion of MTT to 
MTT-formazan by mitochondrial enzymes. For mor-
phological studies, cells were treated with EGL for 
72 hours and photographed directly using an inverted 
microscope (Carl Zeiss, Oberkochen, Germany).
2.2.  Nuclear staining with DAPI
Untreated control and EGL-treated AGS cells were 
harvested and washed with phosphate-buffered 
saline (PBS). The cells were fixed with 3.7% para-
formaldehyde (Sigma-Aldrich) in PBS for 10 minutes 
at room temperature. Fixed cells were collected 
using cytospin, washed with PBS, and stained with 
4,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich) 
solution for 10 minutes at room tem perature. The 
cells were washed two more times with PBS and an-
alyzed via a fluorescence microscope (Carl Zeiss).
2.3.  Measurement of apoptosis by 
annexin-V fluorescein isothiocyanate 
and propidium iodide double staining
The magnitude of the apoptosis elicited by EGL 
treatment was determined using an Annexin-V fluo-
rescein isothiocyanate Apoptosis Detection Kit 
(BD Pharmingen, San Diego, CA, USA). In brief, the 
cells were washed with PBS and resuspended in 
annexin-V binding buffer containing 10 mM HEPES/
NaOH, pH 7.4, 140 mM NaCl, and 2.5 mM CaCl2 ac-
cording to the manufacturer’s protocol. Aliquots 
of the cells were incubated with annexin-V fluo-
rescein isothiocyanate, mixed, and incubated for 
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15 minutes at room temperature in the dark. Pro-
pidium iodide (PI) at a concentration of 5 μg/mL was 
added to identify the necrotic cells. The apoptotic 
cells were measured by a fluorescence-activated 
cell sorter analysis in a flow cytometer (Becton 
Dickinson, San Jose, CA, USA).
2.4.  Protein extraction, gel electrophoresis, 
and western blot analysis
Total cell lysates were lysed in an extraction buffer 
[25 mM Tris-Cl (pH 7.5), 250 mM NaCl, 5 mM eth-
ylenediaminetetra acetic acid, 1% Nonidet P-40, 
0.1 mM sodium orthovanadate, 2 μg/mL leupeptin, 
and 100 μg/mL phenylmethylsulfonyl fluoride]. Pro-
tein concentration was determined with a Bio-Rad 
protein assay kit (Bio-Rad, Hercules, CA, USA). For 
western blot analysis, proteins (30−50 g) were sep-
arated by 8−10% sodium dodecyl sulfate polyacryla-
mide gel electrophoresis and then electrotransferred 
to a nitrocellulose membrane (Schleicher & Schuell, 
Keene, NH, USA). The membranes were blocked 
with 5% skim milk for 1 hour and then subjected to 
immunoblot analysis with the appropriate antibod-
ies. Proteins were subsequently visualized by the 
enhanced chemiluminescence method according 
to the recommended procedure (Amersham Co., 
Arlington Heights, IL, USA). Primary antibodies were 
purchased from Santa Cruz Biotechnology Inc. 
(Santa Cruz, CA, USA) and Calbiochem (Cambridge, 
MA, USA). Peroxidase-labeled donkey anti-rabbit 
immunoglobulin and peroxidase-labeled sheep 
anti-mouse immunoglobulin were purchased from 
Amersham Co.
2.5.  In vitro caspase activity assay
The activities of caspase-3, -8, and -9 were deter-
mined by colorimetric assay kits from R&D Systems 
(Minneapolis, MN, USA) following the manufacturer’s 
protocol. Briefly, the cells were lysed in a lysis buffer 
for 30 minutes in an ice bath. The supernatants were 
collected and incubated at 37ºC with the supplied 
reaction buffer, which contained dithiothreitol and 
the substrates Asp-Glu-Val-Asp-p-nitroaniline for 
caspase-3, Ile-Glu-Thr-Asp-p-nitroaniline for caspase- 
8, and Leu-Glu-His-Asp-p-nitroaniline for caspase-9. 
The optical density of the reaction mixture was 
quantified using a spectrophotometer at a wave-
length of 405 nm.
2.6.  Statistical analysis
Analysis of variance, with a Bonferroni post hoc 
test, and graphical presentations were performed 
by GraphPad Prism version 5 (Hearne Scientific Soft-
ware, Melbourne, Australia). Statistical significance 
was confirmed when p values were less than 0.05 
or 0.01.
3.  Results
3.1.  Growth inhibition and apoptosis 
induction by EGL treatment in 
AGS cells
EGL-induced cell cytotoxicity was determined 
from the effects of various EGL concentrations on 
AGS cell viability using an MTT assay. The data 
showed that treatment with EGL decreased the vi-
ability of AGS cells in a concentration- and time-
dependent manner (Figure 1). Further experiments 
were performed to determine if this inhibitory 
effect of EGL on cell viability was the result of ap-
optotic cell death. Direct observation using an in-
verted microscope demonstrated that the cells 
treated with EGL showed many morphological 
changes compared with control cells (Figure 2A). 
In particular, cell shrinkage, cytoplasm condensation, 
and formation of cytoplasmic filaments appeared 
after 1.5% EGL treatment for 72 hours. Morphological 
analysis with DAPI staining revealed nuclei with 
concentration-dependent chromatin condensation 
and the formation of apoptotic bodies in cells cul-
tured with EGL. In contrast, very few apoptotic cells 
were observed in the control culture (Figure 2B). 
Therefore, flow cytometry analysis with annexin V 
and PI staining was used to determine the magni-
tude of apoptosis elicited by EGL. As shown in 
Figures 2C and 2D, the annexin V-positive cells 
Figure 1 Inhibition of cell viability by ethanol extracts 
of G. lucidum (EGL) in AGS cells. The cells were seeded at 
an initial density of 2.5 × 105 cells per 60 mm plate, incu-
bated for 24 hours, and treated with various concentra-
tions of EGL for the indicated times. The cell viability was 
measured using 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl 
tetrazolium bromide or MTT assay. Each point represents 
the mean ± SD of three independent experiments. Signif-
icance was determined using a Student’s t test (*p < 0.05 
vs. untreated control).
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increased with concentration and length of expo-
sure to EGL, compared with the untreated control 
cells. These results demonstrated that the cytotoxic 
effects observed in response to EGL are associated 
with the induction of apoptosis in AGS cells. A good 
correlation between the extent of apoptosis and 
the inhibition of growth was observed.
3.2.  Modulation of apoptosis-related 
proteins by EGL in AGS cells
To elucidate the apoptotic pathways activated by 
EGL, we used Western blot analyses to measure the 
expression of the death receptors and correspond-
ing pro-apoptotic ligands, as well as the expression 
of the Bcl-2 and IAP family members. As indicated 
in Figure 3, no significant changes of Fas, Fas ligand 
(FasL) and DR 4 protein levels were noted in AGS 
cells treated with EGL, however, EGL increased the 
expression levels of DR5 and necrosis factor-related 
apoptosis-inducing ligand (TRAIL) proteins in a 
concentration- and time-dependent manner. When 
AGS cells were treated with EGL, a clear decrease 
in anti-apoptotic Bcl-2 protein expression was ob-
served without alteration of anti-apoptotic Bcl-xL, 
and pro-apoptotic protein Bax and Bad expression. 
However, treatment with EGL significantly induced 
the cleavage of Bid, a BH3-only proapoptotic mem-
ber of the Bcl-2 family, in a concentration- and 
time-dependent manner. In addition, the levels of 
IAP family proteins, such as XIAP and survivin, but 
not cIAP-1 and cIAP-2, were significantly downreg-
ulated after EGL treatment.
3.3.  Activation of caspases and degradation 
of poly(ADP ribose) polymerase protein 
by EGL treatment
Next, experiments were performed to characterize 
the role of caspase activation in EGL-mediated apop-
tosis in AGS cells. The immunoblotting results showed 
that the levels of active caspase-3, -8, and -9 pro-
teins were increased in a concentration-dependent 
manner in EGL-treated AGS cells (Figure 4A). 
Furthermore, to monitor the enzymatic activity of 
these enzymes during EGL-induced apoptosis, the 
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Figure 2 Induction of apoptosis following treatment of AGS cells with ethanol extracts of G. lucidum (EGL). (A) 
After incubation with various concentrations of EGL for 72 hours, the cells were sampled and examined using an 
inverted microscope (magnification, 200×). (B) Cells grown under the same conditions as (A) were sampled, fixed, 
and stained with 4,6-diamidino-2-phenylindole. The stained nuclei were then observed under a fluorescent micro-
scope using a blue filter (magnification, 400×). (C) AGS cells were treated with various concentrations of EGL for 
72 hours or (D) treated with 2% EGL for the indicated times. The cells were collected and stained with fluorescein 
isothiocyanate-conjugated annexin-V and PI for flow cytometry analysis. The apoptotic cells were determined by 
counting the percent of annexin V(+)/propidium iodide (−) cells and the percent of annexin V(+)/propidium iodide (+) 
cells. The results are expressed as the mean ± SD of three independent experiments. The statistical significance of 
results was analyzed using a Student’s t test (*p < 0.05).
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in vitro caspase activity was measured following 
treatment with EGL using specific fluorogenic pep-
tide substrates for each caspase. As shown in 
Figure 4B, the activities of these caspases were sig-
nificantly increased in a concentration-dependent 
fashion as compared with untreated control cells. 
Subsequent Western blot analyses showed the pro-
gressive proteolytic cleavage of poly(ADP ribose) 
polymerase protein (PARP) in AGS cells after EGL 
treatment (Figure 4A), suggesting that the activa-
tion of caspase is involved in the EGL-induced ap-
optotic pathway.
3.4.  PI3K/Akt inhibitor sensitizes 
EGL-induced apoptosis
The phosphorylation state of the Akt protein in 
AGS cells after EGL treatment was examined to 
determine if EGL-induced apoptosis is closely re-
lated to the Akt signal, a downstream effector of 
PI3K for survival signaling. As shown in Figure 5A, 
the levels of total Akt protein remained unchanged 
by EGL treatment; however, phosphorylation levels 
were markedly decreased in a concentration- and 
time-dependent manner. Thus, the involvement of 
Akt signal pathways in EGL-induced apoptosis was 
examined using the PI3K/Akt inhibitor LY294002 to 
determine if the inhibition of Akt phosphorylation 
was responsible for the induction of apoptosis. As 
shown in Figures 5B and 5C, the combined treat-
ment with EGL and LY294002 significantly de-
creased the phosphorylation levels of Akt and 
increased the cleavage of PARP proteins and apop-
tosis. This indicates that EGL-induced apoptosis is 
associated with the downregulation of the PI3K/
Akt signaling pathway.
4.  Discussion
Recent studies have reported that EGL can cause 
cell cycle arrest and apoptosis. These observations 
suggest that the growth inhibitory effect of the ex-
tracts occurs through the blockage of the G1/S or 
G2/M phase, and that these cells do not enter cell 
cycle progression and die through apoptosis [17−
21,23−25]. While some mechanisms of cell death 
related to these extracts have been suggested 
[17,20−24], the signaling pathway by which they 
occur have not been elucidated in human gastric 
cancer cells. Therefore, the aim of this study was to 
determine the capacity of EGL to induce apoptosis, 
and to identify the biochemical mechanisms in-
volved in a human gastric carcinoma AGS cell line. 
Our present study demonstrated that EGL inhibits 
AGS cell growth by the induction of apoptotic cell 
death through modulation of several apoptosis 
related proteins and activation of caspase. Fur-
thermore, the inhibition of the PI3K/Akt pathway 
enhanced EGL-induced cytotoxic and apoptotic 
effects.
Apoptosis is endogenous programmed cell death 
that can be triggered by various stimuli, including 
DR-mediated signaling (via the DR/extrinsic path-
way) and intracellular stress (via the mitochondrial/
intrinsic pathway). Mitochondria are major regula-
tors of extrinsic, as well as intrinsic, apoptotic path-
ways, and they undergo a series of consequential 
changes during apoptosis. Mitochondrial function 
is controlled by several factors, such as the Bcl-2 
and IAP protein family [1,3−5]. The Bcl-2 family 
significantly regulates apoptosis, either as an acti-
vator (e.g., Bax, Bad, etc.), or as an inhibitor (e.g., 
Bcl-2, Bcl-xL, etc.). It has been suggested, there-
fore, that the Bax/Bcl-2 ratio is a key factor in the 
regulation of the apoptotic process [26,27]. The IAP 
family functions by binding to and inhibiting several 
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Figure 3 Effects of ethanol extracts of G. lucidum (EGL) 
treatment on the levels of apoptosis-related proteins in 
AGS cells. (A) Cells were treated with the indicated con-
centrations of EGL for 72 hours or (B) treated with 2% 
EGL for the indicated times. Equal amounts of cell 
lysates were resolved on sodium dodecyl sulfate poly-
acrylamide gels and transferred to nitrocellulose mem-
branes. The membranes were probed with the indicated 
antibodies and proteins were visualized using the 
enhanced chemiluminescence detection system. Actin 
was used as an internal control.
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caspases [28,29]. Activation of the mitochondrial 
pathway leads to the release of Smac/Diablo, which 
removes the IAP blockage of caspase activation 
[2,6,7]. The present data shows that EGL-induced 
apoptosis was related to the downregulation of 
pro-apoptotic Bcl-2 (Figure 3), which suggests that 
EGL increased the Bax/Bcl-2 ratio and induced mi-
tochondrial dysfunction, leading to apoptosis in AGS 
cells. Fur thermore, exposure of AGS cells to EGL 
caused a downregulation of IAP family proteins such 
as XIAP and survivin (Figure 3).
Cell surface Fas/FasL and TRAIL/DR systems are 
key signaling transduction pathways of the extrin-
sic pathway of apoptosis in cells. Binding FasL to 
Fas receptors or TRAIL to DRs, leads to receptor 
oligomerization and the formation of the death-
inducing signaling complex, followed by the acti-
vation of caspase-8, and then cleavage of Bid (tBid). 
The tBid can translocate to mitochondria and bind 
to Bax, leading to a conformational change of Bax 
and to the activation of caspase-9, and concomi-
tant activation of caspase-3 [6,7]. Thus, caspase-3 
is the most important executioner of apoptosis. 
Significant evidence indicates that caspase-3 is ei-
ther partially or totally responsible for the proteo-
lytic cleavage of many key proteins including PARP. 
PARP is important for cell viability, and the cleavage 
of PARP facilitates cellular disassembly and serves 
as a marker of cells undergoing apoptosis [30]. To 
further gain the mechanical insights of EGL-induced 
apoptosis of AGS cells, the catalytic activity of cas-
pases and the levels of Bid were investigated. The 
present data demonstrated that EGL increased the 
levels of DR5 and TRAIL and the enzymatic activity 
of extrinsic and intrinsic caspase cascades such 
as caspase-8 and -9, and decreased the levels of 
total Bid expression (Figures 3 and 4). In addition, 
caspase-3 was activated and PARP proteins were 
cleaved in EGL-treated AGS cells (Figure 3).
Although the PI3K/Akt signal pathways play a 
critical role in regulating cell survival and death 
in many physiological and pathological settings, 
numerous studies have indicated that these path-
ways are more often associated with cell survival 
through activation of anti-apoptotic downstream 
effectors [8,9]. Therefore, whether EGL-induced 
apoptosis is associated with these pathways was 
also investigated. EGL treatment caused the down-
regulation of Akt activation, and the combined ex-
posure with LY294002, a PI3K/Akt inhibitor, made 
the cells more sensitive to EGL-induced apoptosis 
(Figure 5). These results indicate that the PI3K/
Akt signaling may have a survival role in response 
to EGL-induced apoptosis.
In summary, the results of this study demonstrate 
that EGL triggers apoptosis of AGS cells through 
activation of the intrinsic caspase pathway along 
with the DR-mediated extrinsic pathway. Moreover, 
the inactivation of Akt may play an important role 
in EGL-induced apoptosis. Although, it is still un-
clear if G. lucidum can induce apoptosis through 
other pathways, the results provide new informa-
tion on the possible mechanisms for the anticancer 
activity of G. lucidum.
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Figure 4   Activation of caspases and degradation of poly (ADP ribose) polymerase protein by ethanol extracts of G. luci-
dum (EGL) treatment in AGS cells. (A) After 72 hours incubation with EGL, the cells were lysed and cellular proteins were 
separated by sodium dodecyl sulfate polyacrylamide gels and transferred onto nitrocellulose membranes. The mem-
branes were probed with anti-caspase-3, anti-caspase-8, anti-caspase-9 and anti-poly(ADP ribose) polymerase protein 
antibodies. Proteins were visualized using the enhanced chemiluminescence detection system. Actin was used as an inter-
nal control. (B) Cells grown under the same conditions as (A) were collected and lysed. Aliquots were incubated with Asp-
Glu-Val-Asp-p-nitroaniline, Ile-Glu-Thr-Asp-p-nitroaniline, and Leu-Glu-His-Asp-p-nitroaniline for caspase-3, -8, and -9, 
individually, at 37ºC for 1 hour. The released fluorescent products were measured. The data represents the mean of three 
independent experiments. The statistical significance of results was analyzed by a Student’s t test (†p < 0.01).
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